| People with institution matching "Eli Lilly": Advanced Search | |||||
| Name | Institution | Area | Added by | Date | Bradley J. Baker (Info) | Korea Institute of Science and Technology (KIST) | Optogenetics | bb7559 | 2011‑04‑20 | Sim | David Bredt (Info) | Eli Lilly and Co. | Neurotransmitters | david | 2005‑11‑02 | Sim | Barbara Calamini (Info) | Eli Lilly & Company | rimorimoto | 2020‑07‑23 | Sim | Richard B. Carter (Info) | Merck Research Laboratories | behavioral pharmacology, drug discovery, drug development | rbcarter | 2009‑05‑07 | Sim | Martin Citron (Info) | Eli Lilly | http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=106 | george.perry | 2010‑09‑07 | Sim | Gavin Stewart Dawe (Info) | National University of Singapore | Bevhavioural neuroscience, Neuropsychopharmacology | phcvvv | 2010‑08‑19 | Sim | Yan Dong (Info) | University of Pittsburgh | Motivational and Emotional Memory | yandong | 2007‑10‑24 | Sim | Griffin J. Fitzgerald (Info) | Purdue | Mesocorticolimbic Information Processing in Addiction | griffer00 | 2011‑03‑10 | Sim | Stephen M. Fitzjohn (Info) | Eli Lilly | synaptic plasticity | ansmf | 2007‑12‑07 | Sim | Martin B. Gill (Info) | Bristol-Myers Squibb | neurodegeneration | gtswanson | 2010‑12‑30 | Sim | Anthony Albert Grace (Info) | University of Pittsburgh | Dopamine, schizophrenia, deep brain stimulation, drug abuse, basal ganglia | rn | 2006‑10‑27 | Sim | Beth J Hoffman (Info) | Eli Lilly & Co | hongyu | 2018‑11‑06 | Sim | John R. Huxter (Info) | Eli Lilly, Transpharmation | Electrophysiology, sleep, EEG, translational neuroscience, learning and memory, Hippocampal function | johnhuxter | 2011‑03‑28 | Sim | John T. Isaac (Info) | NIH | Synaptic plasticity; synaptic function; hippocampus; barrel cortex; AMPAR; kianate receptor | isaacj | 2007‑09‑28 | Sim | Johanna S. Jackson (Info) | Eli Lilly | synaptogenesis, two-photon, neurogenesis, synaptic plasticity | jjackson | 2012‑03‑14 | Sim | Barry Matthew Joyce (Info) | Eli Lilly, Co. | kfrogg | 2008‑12‑04 | Sim | David McKinzie (Info) | Eli Lilly | addiction | snap | 2011‑03‑10 | Sim | Richard C. Mohs (Info) | Eli Lilly | http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=58 | george.perry | 2010‑09‑06 | Sim | Richard I. Morimoto (Info) | Northwestern | draible | 2009‑11‑09 | Sim | Eric Nisenbaum (Info) | Lilly | aagrace | 2008‑05‑02 | Sim | Christer E. Nordstedt (Info) | Eli Lilly & Co | Neuroscience, Alzheimer's, Research Management | Christer | 2011‑07‑01 | Sim | Mami Otaka (Info) | Eli Lilly & Co | yandong | 2016‑04‑15 | Sim | Feng Pan (Info) | Pfizer, Inc., Eli Lilly | Neuroscience | fp268 | 2008‑11‑04 | Sim | Steven M. Paul (Info) | Eli Lilly and Co. | Alcohol, GABA, neurosteroids, dementia | CJM3 | 2009‑03‑01 | Sim | Kurt Rasmussen (Info) | Eli Lilly | phcvvv | 2010‑08‑19 | Sim | Phil Skolnick (Info) | NIH | anxiolytic drugs, GABA Receptors, glutamate, benzodiazepines, antidepressants, NMDA receptor | iapaul | 2014‑04‑21 | Sim | Ryan Matthew Smith (Info) | Ohio State, Ohio State, Eli Lilly & Co | Genetics, Autism, Gene Expression, Splicing, Drug Abuse, Schizophrenia, Neuroimaging | lupeyg2 | 2009‑07‑29 | Sim | Xavier N Taylor (Info) | Eli Lilly and Company | Neurodegeneration | xtaylor | 2019‑03‑18 | Sim | Keith A. Wafford (Info) | Eli Lilly | blagburn | 2015‑01‑24 | Sim | Jeffrey M. Witkin (Info) | Eli Lilly | rbcarter | 2009‑05‑07 | Sim | Wu-Kuang Yeh (Info) | Eli Lilly & Co | bb7559 | 2016‑03‑24 | Sim | Hong Yu (Info) | Janssen R&D | AMPA, NMDA, nAchR | hongyu | 2018‑11‑06 | Sim |
| Sign in to add a new person | |||||